It is believed that with the continuous deepening of research, the mechanism of sphingolipids’ involvement in insulin resistance and the mechanism of brain lesions will become clearer, which will bring new targets and hope for the treatment of diabetes, AD, PD, tumor and other related diseases. This evidence concerns the gene INS and diabetes mellitus.